NEW YORK, Aug. 6, 2013 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), operator of Open, Transparent and Connected financial marketplaces, today announced that DSM (OTCQX: RDSMY; NYSE Euronext: DSM), a global science-based company active in health, nutrition and materials, has chosen to have its American Depositary Receipts (ADRs) traded on OTCQX®, the best marketplace with qualified companies.
(Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO )
DSM began trading today on OTCQX International Premier, a segment of the OTCQX marketplace reserved for world-leading companies that are listed on a qualified international exchange, undergo management reviews and provide their home country disclosure to U.S. investors. U.S. investors can find current financial disclosures and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
"We are pleased to welcome DSM to the OTCQX marketplace," said R. Cromwell Coulson, President and CEO of OTC Markets Group. "As one of the leading life sciences and materials sciences companies in the world, DSM exemplifies the high caliber, blue-chip companies trading on OTCQX International Premier. DSM's decision to upgrade to OTCQX demonstrates its commitment to its U.S. investors and to supplying them convenient access to the same timely news and disclosure enjoyed by investors in its home country. We look forward to working with the management team at DSM as they continue to provide a robust, transparent, public market for their shares."
"Upgrading our ADR program to the OTCQX marketplace was the right move for DSM and our investors," said Rolf-Dieter Schwalb, CFO of DSM. "With OTCQX, we can clearly convey our qualifications to the financial markets and ensure our shareholders receive high-quality disclosure, transparent trading and easy access through their regulated U.S. broker-dealer."
Deutsche Bank will serve as DSM's Principal American Liaison ("PAL") on OTCQX, responsible for providing professional guidance on OTCQX requirements.
DSM trades in the U.S. on OTCQX under the symbol "RDSMY," where each ADR represents 1/4 ordinary shares.
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM delivers innovative solutions that nourish, protect and improve performance in global markets such as food and dietary supplements, personal care, feed, pharmaceuticals, medical devices, automotive, paints, electrical and electronics, life protection, alternative energy and bio-based materials. DSM's 23,500 employees deliver annual net sales of around €9 billion. More information can be found at www.dsm.com.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates Open, Transparent and Connected financial marketplaces for 10,000 U.S. and global securities. Through our OTC Link® ATS, we directly link a diverse network of broker-dealers that provide liquidity and execution services for a wide spectrum of securities. We organize these securities into marketplaces to better inform investors of opportunities and risks – OTCQX®, The Best Marketplace with Qualified Companies; OTCQB®, The Venture Stage Marketplace with U.S. Reporting Companies; and OTC Pink®, The Open Marketplace with Variable Reporting Companies. Our data-driven platform enables investors to easily trade through the broker of their choice at the best possible price and empowers a broad range of companies to improve the quality and availability of information for their investors. To learn more about how we create better informed and more efficient financial marketplaces, visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
Subscribe to the OTC Markets RSS Feed
SOURCE OTC Markets Group Inc.
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article